Spijkervet, J.-R.J.A.H.; Lanjouw, L.; Berger, L.P.V.; Dorrius, M.D.; van der Vegt, B.; de Bock, G.H.
Clinicopathological Characteristics of Ovarian and Breast Cancer in PALB2, RAD51C, and RAD51D Germline Pathogenic Variant Carriers. Genes 2025, 16, 556.
https://doi.org/10.3390/genes16050556
AMA Style
Spijkervet J-RJAH, Lanjouw L, Berger LPV, Dorrius MD, van der Vegt B, de Bock GH.
Clinicopathological Characteristics of Ovarian and Breast Cancer in PALB2, RAD51C, and RAD51D Germline Pathogenic Variant Carriers. Genes. 2025; 16(5):556.
https://doi.org/10.3390/genes16050556
Chicago/Turabian Style
Spijkervet, Jella-Rike J. A. H., L. Lanjouw, L. P. V. Berger, M. D. Dorrius, B. van der Vegt, and G. H. de Bock.
2025. "Clinicopathological Characteristics of Ovarian and Breast Cancer in PALB2, RAD51C, and RAD51D Germline Pathogenic Variant Carriers" Genes 16, no. 5: 556.
https://doi.org/10.3390/genes16050556
APA Style
Spijkervet, J.-R. J. A. H., Lanjouw, L., Berger, L. P. V., Dorrius, M. D., van der Vegt, B., & de Bock, G. H.
(2025). Clinicopathological Characteristics of Ovarian and Breast Cancer in PALB2, RAD51C, and RAD51D Germline Pathogenic Variant Carriers. Genes, 16(5), 556.
https://doi.org/10.3390/genes16050556
